Yuan, W., Xu, W., Li, Y., Jiang, W., Li, Y., Huang, Q., . . . Wu, J. (2019). TAZ sensitizes EGFR wild-type non-small-cell lung cancer to gefitinib by promoting amphiregulin transcription. Cell Death Dis.
استشهاد بنمط شيكاغوYuan, Weiwei, et al. "TAZ Sensitizes EGFR Wild-type Non-small-cell Lung Cancer to Gefitinib By Promoting Amphiregulin Transcription." Cell Death Dis 2019.
MLA استشهادYuan, Weiwei, et al. "TAZ Sensitizes EGFR Wild-type Non-small-cell Lung Cancer to Gefitinib By Promoting Amphiregulin Transcription." Cell Death Dis 2019.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.